Hep C Rx changing
December 2, 2015
the latest issue of NPS
MedicineWise’s Australian
Prescriber sees a summary of new
treatments for hepatitis C from
gastroenterologists Alex Thompson
and Jacinta Holmes.
Thompson and Holmes say,
“Hepatitis C treatment has
moved along at a dramatic pace
with a number of direct-acting
drugs recently developed such as
sofosbuvir.
“These drugs target multiple steps
in the viral life cycle and are used in
combination with other medicines.
“Shorter courses are effective,
with minimal toxicity.”
It is estimated that more than
230,000 Australians are chronically
infected with the hepatitis C virus
and while hepatitis C is presently
managed mainly by specialists, with
the advent of these new drugs, it
may be possible for some patients
to be managed in primary care, the
authors said.
The article includes a continuing
professional development activity
for pharmacists.
Other articles in the current issue
include Online pharmacies: buyer
beware, Opioid prescribing pitfalls:
medicolegal and regulatory issues,
Depression in dementia, Medicinal
cannabis (PD yesterday), Updating
the management of sexually
transmitted infections, and a list of
new drugs.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Dec 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Dec 15
